Drug
Eos006215
Eos006215: highest development phase Phase 1, developed by iTeos Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- iTeos Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| EOS006215 NCT06877533 | Phase 1 | Selected Advanced Solid Tumors |
Latest
No recent events.
Follow Eos006215 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.